Miriam G. Ferrara

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Co-targeting hallmarks of cancer for therapeutic benefit in ovarian cancer: a scoping review.

Co-targeting hallmarks of cancer for therapeutic benefit in ovarian cancer: a scoping review.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 12, 2025

PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance.

PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance.

Journal: Therapeutic advances in medical oncology
Published: April 02, 2025

Retroaortic left renal vein associated to variations of liver vasculature and biliary system in a patient submitted to total pancreatectomy.

Retroaortic left renal vein associated to variations of liver vasculature and biliary system in a patient submitted to total pancreatectomy.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: May 20, 2023

Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors.

Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors.

Journal: Critical reviews in oncology/hematology
Published: January 13, 2023

Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer.

Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer.

Journal: Frontiers in oncology
Published: August 23, 2022

Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas.

Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas.

Journal: Expert review of anticancer therapy
Published: June 21, 2022

Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.

Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.

Journal: Seminars in oncology
Published: May 21, 2022

Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?

Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?

Journal: Anticancer research
Published: November 29, 2021

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.

Journal: Journal of hematology & oncology
Published: November 12, 2021

The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures.

The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures.

Journal: Frontiers in oncology
Published: October 10, 2021

Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned.

Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned.

Journal: Cells
Published: September 15, 2021

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.

Journal: Journal for immunotherapy of cancer
Published: March 09, 2021
Showing 1-12 of 27

Last Updated: 09/26/2026